Disclosure Panels Details Page
Breast Cancer Risk Reduction Panel - Disclosures as of 03/19/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Banu Arun MD | AbbVie, Inc. National Cancer Institute |
AstraZeneca Pharmaceuticals LP | None | None | ✔ |
| Mary Anne Bergman | None | None | None | None | ✔ |
| Therese Bevers MD | Menssana Toray International |
None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Graham Colditz MD, DrPH, FAFPHM | None | None | None | GRAIL | ✔ |
| Mary Daly MD, PhD, FACP | None | None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Judy Garber MD, MPH | None | Gtx Pharmaceuticals - SPOUSE Helix Novartis Pharmaceuticals Corporation Oric Pharmaceuticals - SPOUSE |
None | None | ✔ |
| Mary Gemignani MD | None | None | None | None | ✔ |
| William Gradishar MD | Genentech, Inc. Pfizer Inc. |
Eisai Inc. Genentech, Inc. |
None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Erin Hofstatter MD | NA | NA | NA | NA | ✔ |
| Shelley Hwang MD, MPH | None | None | None | None | ✔ |
| Judith Jordan BS | None | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | ✔ |
| Nicole Kounalakis MD | None | None | None | None | ✔ |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| Allison Kurian MD, MSc | Ambry Genetics GeneDx Genomic Health, Inc. InVitae Corporation Myriad Genetic Laboratories, Inc. |
None | None | None | ✔ |
| Loretta Loftus MD, MBA | None | Cardinal Health | None | None | ✔ |
| Martin Mahoney MD, PhD | None | Merck & Co., Inc. Pfizer Inc. |
Merck & Co., Inc. Pfizer Inc. sanofi-aventis U.S. |
None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Sofia Merajver MD, PhD | None | None | None | None | ✔ |
| Ingrid Meszoely MD | None | None | None | None | ✔ |
| Joanne Mortimer MD, FACP | Novartis Pharmaceuticals Corporation Puma |
None | None | None | ✔ |
| Catherine Parker MD | None | None | None | None | ✔ |
| Holly Pederson MD | None | None | Myriad Genetic Laboratories, Inc. | None | ✔ |
| Frances Pritchard MD | None | None | None | None | ✔ |
| Sandhya Pruthi MD | None | None | None | None | ✔ |
| Sagar Sardesai MD, MPH | None | None | None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | ✔ |
| Michelle Specht MD, FACS | None | None | None | None | ✔ |
| Pavan Kumar Tandra MD | None | None | None | None | - |
| Amy Tuten PharmD, BCOP | None | None | None | None | ✔ |
| Kala Visvanathan MD, MHS | Patent pending for genome-wide methylation analysis and use to identify genes specific to breast cancer hormone receptor status and risk of recurrence (Inst); inventor on one or more patents applied for on issues relating to methylation and cancer in the past 2 years and has assigned his/her rights | None | None | None | ✔ |
| Anne Wallace MD, FACS | None | None | None | None | ✔ |
| John Ward MD | None | None | None | None | ✔ |
| Lee Wilke MD, FACS | National Cancer Institute | Elucent Medical | None | American Society of Breast Surgeons | ✔ |
| Rachel Yung MD | None | None | None | None | ✔ |